Martin Babler

Affiliations

  • President, Ceo And Chairman at Alumis Inc. (ALMS), 2024-07-01
  • at Prelude Therapeutics Inc (PRLD), 2024-06-18
  • at 89Bio Inc. (ETNB), 2024-05-03
  • Director at Neoleukin Therapeutics Inc. (NLTX), 2023-06-09
  • Director at Omega Alpha Spac (OMEG), 2021-01-07
  • President, Ceo at Principia Biopharma Inc. (PRNB), 2020-09-28
  • Director at Zs Pharma Inc. (ZSPH), 2015-12-22
  • Director at Infinity Pharmaceuticals Inc. (INFI), 2013-06-13
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
PRNB $62.38 2,502 Officer, Director 810 2020-06-23 Filing
PRNB $61.82 11,983 Officer, Director 3,312 2020-06-23 Filing
PRNB $60.32 515 Officer, Director 15,295 2020-06-23 Filing
PRNB $64.83 300 Officer, Director 39,179 2020-03-03 Filing
PRNB $64.10 5,432 Officer, Director 39,479 2020-03-03 Filing